Table 1 Patient characteristics (n = 121)
From: FDG-PET parameters predicting mediastinal malignancy in lung cancer
Sociodemographic data | |
Age (years), mean (SD) | 65.7 (9.2) |
Gender (female), n (%) | 17 (14.0) |
Tumor characteristics | |
Pathology, n (%) | |
Squamous-cell carcinoma | 46 (38.0) |
Adenocarcinoma | 64 (52.9) |
Large cell carcinoma | 4 (3.3) |
Non-specified non-small cell lung cancer | 7 (5.8) |
Tumor size, n (%): | |
≤ 3 cm | 46 (38.0) |
> 3 cm and ≤7 cm | 57 (47.1) |
> 7 cm | 18 (14.9) |
F-18 fluorodeoxyglucose Positron emission tomography (FDG-PET) | |
SUVmax tumor, mean (SD) | 12.3 (6.3) |
Single hypermetabolic image in the mediastinum, n (%) | 50 (41.3) |
Multiple hypermetabolic images in the mediastinum, n (%) | 44 (36.4) |
SUVmax mediastinum, median (IQR) | 3.9 (2.4-7.0) |
Staging of the mediastinum | |
Malignancy extended to mediastinal lymph nodes | 65 (53.8) |
Technique diagnosing mediastinal malignancy | |
EBUS-NA | 53 (43.8) |
EUS-NA or mediastinoscopy | 6 (5.0) |
Surgical lymphadenectomy | 6 (5.0) |